Analysts were busy on Monday, delivering a mix of upgrades, target price hikes, and a notable cut to chip darling AMD.
Eaton gets the nod. Eaton Corporation earned a consensus upgrade, lifting the average target to $478. The industrial power management company has drawn renewed interest amid strong infrastructure spending tailwinds.
Moderna rises on fresh target. Analysts bumped their average price target for Moderna to $118.59, up from $116.50. The mRNA specialist carries short interest of 13.4% of free float — one of the higher readings among large-cap biotech names. The target lift signals growing confidence in the pipeline despite the elevated bearish positioning.
NVIDIA keeps climbing. NVIDIA received another target price increase, with consensus nudging to $327.65. The AI chip leader remains a near-universal buy among analysts covering it.
AMD trimmed. Analysts cut the average price target for Advanced Micro Devices to $612.62, a small reduction from $613.84. Short interest stays low at 2.5% of free float.
Robinhood recommendation removed. A recommendation was pulled on Robinhood Markets as the fintech trades near its $97B market cap. The stock's short interest sits at just 4.1% of free float, suggesting limited bearish conviction despite the analyst action.
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
